3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
12
Carcinoma, Non-Small-Cell Lung
8
Uterine Cervical Neoplasms
6
Carcinoma, Renal Cell
5
Rectal Neoplasms
4
Pancreatic Neoplasms
4
Colonic Neoplasms
4
Sarcoma
3
Neoplasms
3
Lymphoma
3
Lung Neoplasms
3
Hodgkin Disease
3
Breast Neoplasms, Male
3
Thyroid Neoplasms
2
Thyroid Cancer, Papillary
2
Oropharyngeal Neoplasms
2
Liver Neoplasms
2
Kidney Neoplasms
2
Colorectal Neoplasms
2
Carcinoma, Hepatocellular
2
Adenocarcinoma, Follicular
2
von Hippel-Lindau Disease
1
Vaginal Neoplasms
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Tongue Neoplasms
1
Stomach Neoplasms
1
Stage III Lung Non-Small Cell Cancer AJCC v7
1
Squamous Cell Carcinoma of Head and Neck
1
Spinal Cord Neoplasms
1
Interventions
Carboplatin
12
Bevacizumab
10
Radiotherapy
9
Paclitaxel
9
Erlotinib Hydrochloride
9
Pemetrexed
7
Docetaxel
5
Taxes
4
Cisplatin
4
pegfilgrastim
3
Gemcitabine
3
Cetuximab
3
Radiotherapy, Conformal
2
Filgrastim
2
veliparib
1
romidepsin
1
pegylated granulocyte colony-stimulating factor
1
lentiviral minigene vaccine of COVID-19 coronavirus
1
Watchful Waiting
1
Vinorelbine
1
Topotecan
1
Thalidomide
1
Temozolomide
1
Surgical Procedures, Operative
1
Sorafenib
1
Selenomethionine
1
Radiotherapy, Intensity-Modulated
1
Radiosurgery
1
Radiation
1
Pneumonectomy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Adenocarcinoma, Bronchiolo-Alveolar
×
Fluorodeoxyglucose F18
×
Clear all
No trials found.